Nukkleus Inc
For the period ended Sep 30, 2023. Filed Jul 12, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Jul 12, 2024
DFNS$2.20+12.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
NUKKLEUS INC. AND SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2023 and 2022
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2023 and 2022
CONTENTS
| Report of Independent Registered Public Accounting Firm – GreenGrowth CPAs (PCAOB ID 6580) | F-3 |
|---|---|
| Report of Independent Registered Public Accounting Firm – Marcum LLP (PCAOB ID 688) | F-4 |
| Consolidated Financial Statements: | |
| Consolidated Balance Sheets - As of September 30, 2023 and 2022 | F-5 |
| Consolidated Statements of Operations and Comprehensive Loss - For the Years Ended September 30, 2023 and 2022 | F-6 |
| Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - For the Years Ended September 30, 2023 and 2022 | F-7 |
| Consolidated Statements of Cash Flows – For the Years Ended September 30, 2023 and 2022 | F-8 |
| Notes to Consolidated Financial Statements | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.